Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,182.6
1.3 (0.04%)

 

  • STI Straits Times Index
    3,182.6
    1.3 (0.04%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,550.5
    -1.2 (-0.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,160.6
    -779.8 (-2.79%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,976.5
    -84.2 (-2.75%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,379.4
    163.7 (0.71%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,113.0
    1.9 (0.03%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,185.3
    8.6 (0.39%)
    Index delayed 20 minutes
  • XAO XAO
    7,135.9
    37.5 (0.53%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,408.5M
  • Value: 1,025.2M
  • Rise: 211
  • Fall: 124
  • Unch: 481

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Medtecs Intl0.196+0.024
Healthway Med0.044-0.002
UG Healthcare0.375+0.125
AsiaMedic0.017-
Golden Agri-Res0.220-0.005
Genting Sing0.870-0.005
Rex Intl0.174+0.006
Thomson Medical0.063-
MarcoPolo Marine0.023+0.002
Ntegrator Intl0.012+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,269.7 +130.4
HSI 27,160.6 -779.8
HSCEI 10,618.7 -350.5
Jakarta 6,113.0 +1.9
Nikkei 225 23,379.4 +163.7
SSE Comp 2,976.5 -84.2
Shanghai A 3,118.9 -88.2
Shanghai B 248.6 -8.9
PSE Comp 0.0
KOSPI 2,185.3 +8.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

HTG MOLECULAR DIAGNOSTICS INC HTG MOLECULAR DIAGNOSTICS
Updated on 28 Jan 2020 (End of trading day)
Last (USD): 0.574 Change: -0.009 High: 0.605 Remarks: -
Change (%): -1.56 Low: 0.562
Open 0.600 Yesterday's Close 0.5826
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 291,389 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.28348 Trailing EPS (USD) e -0.29351 NAV (USD) b 0.4844
PE a - Trailing PE f - Price / NAV b 1.1839
Dividend (USD) d - Cash In Hand (USD) g 0.6004 Issued & Paid-up Shares c 58,042,000
Dividend Yield (%) d - Price / Cash In Hand g 0.955 Treasury Shares h -
Beta - 75 Daysi -0.505 R-Squared - 75 Days(%)i 0.01 Market Cap (M) 33.287
Beta - 500 Daysi -0.262 R-Squared - 500 Days (%)i 0.41 Enterprise Value (M) 12.839
Piotroski F Score 3 Exchange Code HTGM Par Value ( $ ) n.a.
52 Weeks Volatility (%) 71.84 Free Float (%) 75.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 16 May 2017.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference HTG MOLECULAR DIAGNOSTICS INC NASDAQ 33.287 - - 1.1839 -
Industry Biotechnology NASDAQ 2,348.378 361.842 92.382 5.8406 0.755
Local Peer AMGEN INC NASDAQ 133,596.331 15.916 16.561 12.2263 2.488
Local Peer GILEAD SCIENCES INC NASDAQ 81,425.054 14.927 30.236 3.9519 3.590
Local Peer VERTEX PHARMACEUTICAL NASDAQ 59,651.086 28.454 27.825 11.3548 -
Local Peer BIOGEN INC NASDAQ 50,875.622 11.483 9.429 3.6350 -
Local Peer ILLUMINA INC NASDAQ 46,199.160 55.931 47.481 10.4076 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 37,778.597 15.455 17.619 3.5965 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,671.498 305.045 16.100 2.2833 -
Local Peer SEATTLE GENETICS INC NASDAQ 19,354.621 - - 10.8758 -
Local Peer INCYTE CORPORATION NASDAQ 16,469.255 150.414 40.668 6.7984 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 15,427.991 - - 5.0182 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 14,891.517 - 47.981 5.3877 -
Local Peer EXACT SCIENCES CORP NASDAQ 13,355.415 - - 17.8482 -
Other Local Peers ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), 10X GENOMICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), REPLIGEN CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), FIBROGEN INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), XENCOR INC (NASDAQ), INSMED INC (NASDAQ), ALECTOR INC (NASDAQ), REGENXBIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), VERACYTE INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), DERMIRA INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), INTREXON CORP (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), VANDA PHARMACE INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), CYTOKINETICS INC (NASDAQ), AVROBIO INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RETROPHIN INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ARDELYX INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), AGENUS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), MERUS B V (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), CABALETTA BIO INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), MEDICINOVA INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), KAMADA (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), VBI VACCINES INC CDA (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), ATHERSYS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), XOMA CORP (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHIASMA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ARAVIVE INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VERASTEM INC (NASDAQ), VACCINEX INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), SAVARA INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CHIMERIX INC (NASDAQ), SESEN BIO INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), COHBAR INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), EQUILLIUM INC (NASDAQ), SYNLOGIC INC (NASDAQ), INFLARX N V (NASDAQ), TREVENA INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VERMILLION INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), SOLIGENIX INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), CURIS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), ZAFGEN INC (NASDAQ), EVOGENE LTD (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), OCUGEN INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TROVAGENE INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), BIOCEPT INC (NASDAQ), TOCAGEN INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), SENESTECH INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 143,467.561 53.474 53.474 19.1721 0.839
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,041.754 85.575 25.249 5.6954 0.701
Global Peer SINO BIOPHARM HKEx 139,587.119 13.027 13.520 4.1570 0.659
Global Peer WUXI BIO HKEx 131,906.697 176.604 138.064 13.5781 -
Global Peer BEIGENE HKEx 95,512.095 - - 9.5298 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer GENSCRIPT BIO HKEx 34,520.656 207.598 - 9.7349 -
Global Peer 3SBIO HKEx 26,720.484 17.663 21.499 2.6336 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,878.038 45.902 669.311 2.7807 -
Other Global Peers ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), MYOVANT SCIENCES LTD (NYSE), MESOBLAST LTD (ASX), CKLIFE SCIENCES (HKEx), FRONTAGE (HKEx), AVITA MEDICAL LTD (ASX), VIVA BIOTECH (HKEx), KADMON HLDGS INC (NYSE), ASCENTAGE-B (HKEx), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ARCUS BIOSCIENCES INC (NYSE), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), DPHARMA (Bursa), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), TELIX PHARMACEUTIC (ASX), BBI LIFE SCI (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CEL-SCI CORP (NYSE American), PYC THERAPEUTICS LIMITED (ASX), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), RESAPP HEALTH LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), IMUGENE LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), IMMUTEP LTD (ASX), ONCOSIL MEDICAL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), ORTHOCELL LIMITED (ASX), CT ENTERPRISE (HKEx), ISORAY INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), BIOTRON (ASX), EXTRAWELL PHAR (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), BIOSINO BIO-TEC (HKEx), KAZIA THERAPEUTICS LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), ANTEOTECH LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), BIONOMICS LTD (ASX), MEMPHASYS LTD (ASX), REGENT PACIFIC (HKEx), TALI DIGITAL LIMITED (ASX), IBIO INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), ORAGENICS INC (NYSE American), RHINOMED LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED (ASX), CELLMID LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), Suntar Eco-City^ (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), REGENEUS LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), AIM IMMUNOTECH INC (NYSE American), BENITEC BIOPHARMA LTD (ASX), BIOXYNE LIMITED (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), MGRC (Bursa), HAO WEN HLDGS (HKEx), QT Vascular (SGX), MEDIBIO LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), NANOLLOSE LTD (ASX), BPH ENERGY LIMITED (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.035
-5.83 %
10 Days --0.092
-13.89 %
20 Days --0.129
-18.30 %
Medium Term Return 3 Months --0.376
-39.57 %
6 Months --0.756
-56.88 %
1 Year --1.556
-73.08 %
Long Term Return 2 Years --2.997
-83.94 %
3 Years --1.107
-65.86 %
Annualised Return Annualised --
-30.11 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.550 - 3.240 Change From 1 Year Low +0.024 % Change From 1 Year Low (%) +4.27
Change From 1 Year High -2.667 % Change From 1 Year High (%) -82.30
2 Years Range 0.550 - 5.830 Change From 2 Years Low +0.024 % Change From 2 Years Low (%) +4.27
Change From 2 Years High -5.256 % Change From 2 Years High (%) -90.16
5 Years Range 0.550 - 19.750 Change From 5 Years Low +0.024 % Change From 5 Years Low (%) +4.27
Change From 5 Years High -19.177 % Change From 5 Years High (%) -97.10
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. Its customers include biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Historical Price Data

Date Open High Low Close Volume VWAP
28 Jan 2020 0.600 0.605 0.562 0.574 291,389 -
27 Jan 2020 0.620 0.620 0.550 0.583 984,637 -
24 Jan 2020 0.662 0.670 0.600 0.617 827,501 -
23 Jan 2020 0.620 0.665 0.570 0.659 3,644,685 -
22 Jan 2020 0.620 0.620 0.600 0.609 365,613 -
21 Jan 2020 0.660 0.660 0.600 0.620 544,459 -
17 Jan 2020 0.680 0.690 0.650 0.658 276,509 -
16 Jan 2020 0.670 0.680 0.650 0.670 356,612 -
15 Jan 2020 0.700 0.700 0.660 0.666 373,345 -
14 Jan 2020 0.720 0.730 0.689 0.689 293,922 -
13 Jan 2020 0.800 0.800 0.711 0.730 280,257 -
10 Jan 2020 0.720 0.795 0.700 0.795 672,391 -
09 Jan 2020 0.711 0.720 0.680 0.707 308,795 -
08 Jan 2020 0.730 0.750 0.700 0.720 231,721 -
07 Jan 2020 0.785 0.790 0.710 0.753 375,775 -
06 Jan 2020 0.850 0.850 0.750 0.770 320,547 -
03 Jan 2020 0.756 0.870 0.756 0.825 580,641 -
02 Jan 2020 0.679 0.770 0.679 0.756 267,543 -
31 Dec 2019 0.680 0.730 0.673 0.702 336,349 -
30 Dec 2019 0.705 0.710 0.660 0.670 426,216 -
27 Dec 2019 0.700 0.750 0.660 0.699 498,396 -
26 Dec 2019 0.750 0.762 0.686 0.698 952,824 -
Summary
Current 2 Weeks
(14 Jan 2020 to 28 Jan 2020)
0.720 0.730 0.550 0.574 7,958,672 -
Previous 2 Weeks
(30 Dec 2019 to 13 Jan 2020)
0.705 0.730 0.550 0.730 3,800,235 -
4 Weeks from
(29 Nov 2019 to 27 Dec 2019)
0.657 0.730 0.550 0.699 7,531,778 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.